 |
|
|
| |
Occurrence of Hypersensitivity Reaction and Hepatotoxicity in Patients Receiving Integrase inhibitors Results from the EuroSIDA study.
|
| |
| |
Reported by Jules Levin
16thEuropean AIDS Conference 2017 Milan, Italy Oct 23-35
Leah Shepherd1, Lars Peters2, Josip Begovac3, Thomas Benfield4, Lloyd Curtis5, StéphaneDe Wit6, Andrzej Horban7, ElzbietaJablonowska8, Margaret Johnson9, Irina Khromova10, Marcelo H Losso11, Jens Lundgren2, Lars N. Nielsen12, Dorthe Raben2, Anna Lisa Ridolfo13, Brigitte Schmied14, Christoph Stephan15, Anders Thalme16, Vani Vannappagari17, Israel Yust18, Ole Kirk2, Amanda Mocroft11Research department of infection and population health, University College London, London, UK;2Centre of Excellence for Health, Immunity and Infection (CHIP), Department of Infectious Diseases, Rigshospitalet, Universityof Copenhagen, Copenhagen, Denmark;3University Hospital of Infectious Diseases, Croatia;4HvidovreUniversitetsHospital, Denmark;5GlaxoSmithKline, UK ;6CHU Saint-Pierre, Belgium7WojewodzkiSzpitalZakazny, Poland;8WojewodzkiSzpitalSpecjalistyczny, Poland;9Royal Free & U.C. Med. School,UK;10Centre for HIV/AIDS & and infectious diseases, Russia;11Hospital J.M. Ramos Mejia, Argentina;12NordsjællandsHospital, Hillerod, Denmark;13OspedaleL. Sacco, Italy;14SMZ / Baumgartner Höhe1, Austria;15 J.W.GoetheUniversity Hospital, Germany;16KarolinskaUniversity Hospital Huddinge, Sweden;17ViiV Healthcare, USA 18IchilovHospital, Israel
|
| |
|
|
|
|
|
